Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
30399 | 138 | 25.3 | 65% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1986 | 5072 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TRANDOLAPRIL | Author keyword | 17 | 32% | 32% | 44 |
2 | MULTI PHOTON CONTAMINATION | Author keyword | 1 | 100% | 1% | 2 |
3 | VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY | Author keyword | 1 | 100% | 1% | 2 |
4 | VERAPAMIL TRANDOLAPRIL | Author keyword | 1 | 100% | 1% | 2 |
5 | VERAPAMIL SR | Author keyword | 1 | 22% | 3% | 4 |
6 | BLOOD PRESSURE 24 HOUR MONITORING | Author keyword | 1 | 50% | 1% | 1 |
7 | LISINOPRIL HYDROCHLOROTHIAZIDE | Author keyword | 1 | 50% | 1% | 1 |
8 | MULTIFACTORIAL TRIAL | Author keyword | 1 | 50% | 1% | 1 |
9 | PRIMARY HYPERTENSION CONTROLLED TRIAL | Author keyword | 1 | 50% | 1% | 1 |
10 | SECT STUDY HLTH POMERANIA CLIN EPIDEMIOL | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VERAPAMIL SR | 4 | 75% | 2% | 3 |
2 | RU 44570 | 1 | 100% | 1% | 2 |
3 | TROUGH PEAK RATIOS | 1 | 100% | 1% | 2 |
4 | BENAZEPRIL MONOTHERAPY | 0 | 25% | 1% | 1 |
5 | INCREASED CALCIUM SENSITIVITY | 0 | 20% | 1% | 1 |
6 | INHIBITOR TRANDOLAPRIL | 0 | 11% | 1% | 1 |
7 | INTESTINAL ABSORPTION COMPONENTS | 0 | 10% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Trandolapril: A newer angiotensin-converting enzyme inhibitor | 2003 | 16 | 73 | 52% |
Trandolapril/verapamil sustained release - A review of its use in the treatment of essential hypertension | 2005 | 3 | 49 | 43% |
Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients | 2008 | 10 | 43 | 12% |
Trandolapril - An update of its pharmacology and therapeutic use in cardiovascular disorders | 1998 | 10 | 65 | 34% |
Trandolapril in left ventricular dysfunction after myocardial infarction: Focus on the trace study | 2003 | 2 | 33 | 30% |
PROFILE OF THE NEW ACE-INHIBITOR TRANDOLAPRIL (RU-44570) | 1994 | 0 | 65 | 42% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT STUDY HLTH POMERANIA CLIN EPIDEMIOL | 1 | 50% | 0.7% | 1 |
2 | CIC1418 | 0 | 33% | 0.7% | 1 |
3 | CO 11 | 0 | 33% | 0.7% | 1 |
4 | ALBERT E EIN MED HOSP | 0 | 25% | 0.7% | 1 |
5 | MED CARE INTERNAL MED | 0 | 25% | 0.7% | 1 |
6 | PARTNERINGCARE SENIOR SERV | 0 | 14% | 0.7% | 1 |
7 | INVEST BIOMED AUGUSTO PI SURIER | 0 | 100% | 0.7% | 1 |
8 | UNITAT HYPERTENSIO | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000222298 | CAS 89396 94 1//TA 6366//MOEXIPRIL |
2 | 0.0000160372 | ADR MONITORING//BOVINE BRONCHI//ACE I INHIBITOR |
3 | 0.0000150344 | AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY |
4 | 0.0000088181 | ZOFENOPRIL//INFARCT EXPANSION//ANGIOTENSIN II AT1 RECEPTOR BLOCKADE |
5 | 0.0000085676 | HAIR DISTRIBUTION//PHYS ACT SPORT RECREAT PHASREC//HART |
6 | 0.0000078426 | DUAL BLOCKADE//RENOPROTECTION//NONDIABETIC RENAL DISEASE |
7 | 0.0000070751 | TERTIARY PHOSPHINE OXIDES//AMINOMETHYL DIMETHYL PHOSPHINE OXIDE//INORGAN CHEM STRUCT CHEM |
8 | 0.0000069695 | AMBULATORY BLOOD PRESSURE MONITORING//AMBULATORY BLOOD PRESSURE//WHITE COAT HYPERTENSION |
9 | 0.0000062550 | MYOCARDIAL COLLAGEN CONCENTRATION//HYPERTROPHY REVERSAL//REGIONAL SYMPATHETIC ACTIVITY |
10 | 0.0000061164 | MINICHAL//ANTIHYPERTENSIVE DRUG CLASSES//ANTIHYPERTENSIVE REGIMENS |